01 / Research

Filing-backed research notes

Daily analysis of Indian market events grounded in real corporate filings. Every claim is backed by what companies actually said in their annual reports and quarterly results.


Deep Dive 16 October 2026

The Supreme Court voided Yes Bank's ₹8,415 crore AT-1 write-off. Yes Bank has no AT-1 left — the filings show the exposure now sits in PSU bank capital stacks

Yes Bank's own filings show Additional Tier 1 capital of nil since 2023, and no provision for the ₹8,415 crore case. Canara Bank (₹17,853 cr) and PNB (₹14,090 cr) still fund ~2% of RWA with AT-1, while Federal, IndusInd, RBL and IDFC First carry none.

YESBANKCANBKPNBSBINBANKINDIAFEDERALBNKINDUSINDBKRBLBANKIDFCFIRSTBKTKBANKDCBBANKTMB
Deep Dive 15 October 2026

Fairfax just won 60.72% of IDBI Bank. CSB Bank's annual report, filed eight days earlier, says its Fairfax stake is already on an RBI dilution schedule — with voting capped at 26%

Cabinet cleared Fairfax's Rs 52,878 crore purchase of 60.72% of IDBI Bank. Filings show Fairfax already promotes five NSE-listed companies — and CSB Bank's FY26 annual report says its 40% Fairfax stake is on an RBI-mandated dilution schedule with voting rights capped at 26%.

CSBBANKIIFLCAPSTHOMASCOOKQUESSBLUSPRINGFAIRCHEMORIDBI
Deep Dive 14 October 2026

RBI's new 20% forex reserve only charges hedges that buy dollars — the filings show who nets imports against exports, and who books both legs gross

The RBI's new Foreign Exchange Risk Reserve applies only to hedges that buy foreign currency against the rupee. Filings from Ambuja Cements, TNPL, GHCL, Pidilite, Rico Auto and Federal Bank show exactly who pays and who already nets.

AMBUJACEMTNPLGHCLPIDILITINDRICOAUTOFEDERALBNK
Deep Dive 13 October 2026

India's draft steel policy promises 604 MT. Its own footnote cuts induction furnaces from 38% of output to 15% — and the filings name who collects

The draft National Steel Policy Vision 2047 assumes EAF share rises to 30% while induction furnaces fall to 15%. Filings from HEG, Graphite India, Vardhman Special Steels, JSW Steel, Tata Steel and Godawari Power show who gains and who pays.

HEGGRAPHITEVSSLJSWSTEELTATASTEELGPIL
Sector Insight 12 October 2026

India Inc is going captive on green power. The filings show the saving lands on cement and chemical P&Ls — and the developers are paying for it in tariff

Open-access solar additions were flat in 2025 (+0.5%). UltraTech buys renewable power at Rs 4.4/kWh vs Rs 7.4 grid; CleanMax realised tariff has fallen four years running. Who actually captures the captive-power saving.

ULTRACEMCODALBHARATORIENTCEMGUJALKALICLEANMAXKPIGREENWAAREERTL
Deep Dive 9 October 2026

Washington suspended green cards for Infosys, TCS, Wipro and HCL. Their own filings say visas were never the exposure.

The US Labor Department suspended eight IT employers from the PERM green-card route. Filings show the named Indian firms are the least visa-dependent — and the real onsite cost exposure sits in unnamed mid-caps.

INFYHCLTECHTECHMTCSZENSARTECHCIGNITITECMPHASISSAGILITYHEXTLATENTVIEW
Deep Dive 8 October 2026

RBI Just Made Account Aggregators Interchangeable. The Filings Say That's A Problem For The 'AA Trade'

RBI's account aggregator interoperability and bank-deposits-in-CAS reforms lifted CAMS and Pine Labs. Filings show AA share already slipping at CAMS, CDSL's eCAS income at just Rs 9.37 crore a quarter, and KFintech declining to control India's largest AA.

CAMSCDSLKFINTECHPINELABSPROTEAN
Deep Dive 7 October 2026

India's five new dumping probes: the filings already name the winner — and who quietly pays

DGTR opened five anti-dumping probes on 5-6 October. Hindalco built India only inner-grooved copper tube plant; GSFC has been bleeding on caprolactam. Century Enka, Blue Star and Epack Durable buy the very inputs now under investigation.

HINDALCOGSFCCENTENKABLUESTARCOEPACKACEALKEM
Deep Dive 6 October 2026

SEBI Is Reverting Derivatives Settlement to a 30-Minute VWAP — Filings Show Angel One Books 77% of Broking Revenue There, and BSE's Cash-Market Fees Are Shrinking

SEBI will stop using the new Closing Auction Session to set derivatives settlement prices, reverting to a 30-minute VWAP while the cash market keeps the auction. Filings quantify who is actually exposed: Angel One at ~77% of gross broking revenue, BSE at ~80% of revenue from transaction charges, and CDSL at none.

ANGELONEBSESMCGLOBALIIFLCAPS5PAISACDSL
Deep Dive 5 October 2026

RBI decides Wednesday. These seven companies already published exactly what a hike costs them

Ahead of the 5-7 October MPC, Ind AS 107 interest-rate sensitivity notes in FY26 annual reports show Tata Power at Rs 208 crore per 50bp while Vedanta, UPL, JSW Energy, Adani Ports and Ashok Leyland are far less exposed than their rate-sensitive labels suggest.

TATAPOWERPFCVEDLUPLJSWENERGYADANIPORTSASHOKLEY
Opportunity 2 October 2026

Scotch just got cheaper in India. The filings say Indian whisky makers are the buyers, not the victims

The India-UK pact cut Scotch duty from 150% to 75%. Radico imports over Rs 250 crore of bulk Scotch a year, Tilaknagar just bought Imperial Blue, and Allied Blenders blends Scotch malts - the duty cut is their input cost cut.

RADICOTIABDLPICCADIL
Deep Dive 1 October 2026

India Renewed Its Export Refund Schemes for 92 Days — Filings Show One Exporter's Rebate Is Bigger Than All Its Pre-Tax Profit

RoDTEP and RoSCTL were extended only to 31 December 2026. Filings show Apex Frozen Foods, Gokaldas, Welspun Living and Nitin Spinners lean on these rebates for a large share of pre-tax profit.

APEXGOKEXWELSPUNLIVGALAPRECNITINSPINCOASTCORPRITES
Deep Dive 30 September 2026

Trump Says His Tariffs Bought Essar's $18 Billion Iowa Steel Mill — Filings Show What Onshoring Actually Cost the Indian Companies That Went First

Essar will spend $15-18bn on a US steel mill. Filings show Hindalco/Novelis's Alabama plant went from $2.5bn to $5bn — tariffs named as a cause — while Jash, Sansera, TD Power and Rajratan chose differently.

HINDALCOJASHSANSERATDPOWERSYSRAJRATANWELSPUNLIV
Deep Dive 29 September 2026

India Was Exempted From the Pharma Tariff on Drugs It Barely Sells — Filings Show Sun Pharma Moved $1 Billion of Sales Into the Bucket That Wasn't Spared

The US 100% pharma tariff's speciality carve-out covers rare-disease, gene and fertility drugs. NSE filings show only Zydus really sells those, while Sun Pharma's Innovative Medicines business — now 21.9% of sales — sits outside the exemption.

SUNPHARMAZYDUSLIFESENORESAUROPHARMALUPIN
Deep Dive 28 September 2026

India's Chip Mission Looks Short of Cash — Filings Show ₹771 Crore Already Banked, and One "Semiconductor Revenue" Line Is Mostly an Acquisition

Business Standard says India's chip push faces a funding gap. Filings show CG Power banked ₹601 crore of grants and Kaynes ₹170 crore — while the segment still loses money.

CGPOWERKAYNESTIINDIASAHASRAACI